Synergistic Activity and Biofilm Formation Effect of Colistin Combined with PFK-158 Against Colistin-Resistant Gram-Negative Bacteria

References

• Luepke KH, Mohr JF. The antibiotic pipeline: reviving research and development and speeding drugs to market. Expert Rev Anti Infect Ther. 2017;15:425–433. doi:10.1080/14787210.2017.130825128306360
   PubMed Web of Science ®Google Scholar
• Falagas ME, Mavroudis AD, Vardakas KZ. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect? Expert Rev Anti Infect Ther. 2016;14(8):747–763. doi:10.1080/14787210.2016.120491127400643
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu W, Qian K. In-vitro antibacterial effect of tea polyphenols combined with common antibiotics on multidrug-resistant Klebsiella pneumoniae. Minerva Med. 2020;111(6):536–543. doi:10.23736/S0026-4806.20.06459-932340432
   PubMed Web of Science ®Google Scholar
• MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med. 2017;32(1):25–37. doi:10.1177/088506661561989526772199
   PubMed Web of Science ®Google Scholar
• Prabaker K, Weinstein RA. Trends in antimicrobial resistance in intensive care units in the United States. Curr Opin Crit Care. 2011;17:472–479. doi:10.1097/MCC.0b013e32834a4b0321900766
   PubMed Web of Science ®Google Scholar
• Abd El-Baky RM, Masoud SM, Mohamed DS, et al. Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa. Infect Drug Resist. 2020;13:323–332. doi:10.2147/IDR.S23881132099423
   PubMed Web of Science ®Google Scholar
• Mavroidi A, Likousi S, Palla E, et al. Molecular identification of tigecycline-and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013. J Med Microbiol. 2015;64:993–997. doi:10.1099/jmm.0.00012726297501
   PubMed Web of Science ®Google Scholar
• Parisi SG, Bartolini A, Santacatterina E, et al. Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 to December 2014. BMC Infect Dis. 2015;15:244. doi:10.1186/s12879-015-0996-726116560
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Diene SM, Kempf M, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014;44:500–507. doi:10.1016/j.ijantimicag.2014.07.02025264127
   PubMed Web of Science ®Google Scholar
• Çağlan E, Nigiz Ş, Sancak B, et al. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii. Acta Microbiol Immunol Hung. 2020;67(2):107–111. doi:10.1556/030.66.2019.02131813259
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–1341. doi:10.1086/42932315825037
   PubMed Web of Science ®Google Scholar
• Wijesinghe GK, Feiria SB, Maia FC, et al. In-vitro antibacterial and antibiofilm activity of Cinnamomum verum leaf oil against Pseudomonas aeruginosa, Staphylococcus aureus and Klebsiella pneumoniae. An Acad Bras Cienc. 2021;93(1):e20201507. doi:10.1590/0001-376520212020150733656062
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang X, Zhang S, et al. Maipomycin A, a novel natural compound with promising anti-biofilm activity against gram-negative pathogenic bacteria. Front Microbiol. 2021;11:598024. doi:10.3389/fmicb.2020.59802433510721
   PubMed Web of Science ®Google Scholar
• Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014;37:119–127.24858639
   PubMed Web of Science ®Google Scholar
• Yeo HJ, Yoon SH, Lee SE. Bacterial biofilms on extracorporeal membrane oxygenation catheters. ASAIO J. 2018;64(4):e48–e54. doi:10.1097/MAT.000000000000075029356690
   PubMed Web of Science ®Google Scholar
• Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013;121:1–51.
   Google Scholar
• Chiang WC, Nilsson M, Jensen P. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2013;57:2352–2361. doi:10.1128/AAC.00001-1323478967
   PubMed Web of Science ®Google Scholar
• Mellbye B, Schuster M. The sociomicrobiology of antivirulence drug resistance: a proof of concept. Mbio. 2011;2:119. doi:10.1128/mBio.00131-11
   Web of Science ®Google Scholar
• Boisvert AA, Cheng MP, Sheppard DC. Microbial biofilms in pulmonary and critical care diseases. Ann Am Thorac Soc. 2016;13:1615–1623. doi:10.1513/AnnalsATS.201603-194FR27348071
   PubMed Web of Science ®Google Scholar
• Tanner WD, Atkinson RM, Goel RK. Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms. FEMS Microbiol Lett. 2017;364:1–6. doi:10.1093/femsle/fnx048
   Web of Science ®Google Scholar
• Mondal S, Roy D, Bhattacharya S, et al. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. Int J Cancer. 2019;144:178–189. doi:10.1002/ijc.3186830226266
   PubMed Web of Science ®Google Scholar
• Gustafsson NMS, Färnegårdh K, Bonagas N, et al. T. Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination. Nat Commun. 2018;9:3872. doi:10.1038/s41467-018-06287-x30250201
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Li X, et al. Synergistic effect of colistin combined with PFK-158 against colistin-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2019;63:e00271–19. doi:10.1128/AAC.00271-1930988150
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Stokes JM, MacNair CR, Ilyas B, et al. Pentamidine sensitizes gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat Microbiol. 2017;2:17028. doi:10.1038/nmicrobiol.2017.2828263303
   PubMed Web of Science ®Google Scholar
• Berard X, Stecken L, Pinaquy JB, et al. Comparison of the antimicrobial properties of silver impregnated vascular grafts with and without triclosan. Eur J Vasc Endovasc Surg. 2016;51:285–292. doi:10.1016/j.ejvs.2015.10.01626680451
   PubMed Web of Science ®Google Scholar
• Zakuan ZD, Suresh K. Rational use of intravenous polymyxin B and colistin: a review. Med J Malaysia. 2018;73:351–359.30350826
   PubMedGoogle Scholar
• O’Loughlin CT, Miller LC, Siryaporn A, et al. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci USA. 2013;110(44):17981–17986. doi:10.1073/pnas.131698111024143808
   PubMed Web of Science ®Google Scholar
• Li Y, Huang J, Li L, Liu L. Synergistic activity of berberine with azithromycin against Pseudomonas Aeruginosa isolated from patients with cystic fibrosis of lung in vitro and in vivo. Cell Physiol Biochem. 2017;42(4):1657–1669. doi:10.1159/00047941128738346
   PubMedGoogle Scholar
• Das MC, Sandhu P, Gupta P, et al. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: a combinatorial study with azithromycin and gentamicin. Sci Rep. 2016;6(1):23347. doi:10.1038/srep2334727000525
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/CMR.00064-1628275006
   PubMed Web of Science ®Google Scholar
• Dharani S, Kim DH, Shanks RMQ, et al. Susceptibility of colistin-resistant pathogens to predatory bacteria. Res Microbiol. 2018;169(1):52–55. doi:10.1016/j.resmic.2017.09.00128919044
   PubMed Web of Science ®Google Scholar
• Ozger HS, Cuhadar T, Yildiz SS, et al. In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates. J Antibiot. 2019;72(8):600–604. doi:10.1038/s41429-019-0188-6
   Web of Science ®Google Scholar
• Falagas ME, Voulgaris GL, Tryfinopoulou K, et al. Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals. Int J Antimicrob Agents. 2019;53(6):855–858. doi:10.1016/j.ijantimicag.2019.02.02130836109
   PubMed Web of Science ®Google Scholar
• Vidaillac C, Benichou L, Duval RE. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2012;56(9):4856–4861. doi:10.1128/AAC.05996-1122751540
   PubMed Web of Science ®Google Scholar
• Bidaud AL, Djenontin E, Botterel F, et al. Colistin interacts synergistically with echinocandins against Candida auris. Int J Antimicrob Agents. 2020;55(3):105901. doi:10.1016/j.ijantimicag.2020.10590131954831
   PubMed Web of Science ®Google Scholar
• Domalaon R, De Silva PM, Kumar A, et al. The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in gram-negative bacilli. Antimicrob Agents Chemother. 2019;63(4):e02574–18. doi:10.1128/AAC.02574-1830917988
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Principato S, Colavecchio OL, et al. Synergistic activity of colistin in combination with resveratrol against colistin-resistant gram-negative pathogens. Front Microbiol. 2018;9:1808. doi:10.3389/fmicb.2018.0180830131787
   PubMed Web of Science ®Google Scholar
• Pollini S, Boncompagni S, Maggio D, et al. In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. J Antimicrob Chemother. 2018;73:2388–2395. doi:10.1093/jac/dky18529846610
   PubMed Web of Science ®Google Scholar
• Inci A, Toker MK, Bicer IG, et al. Determination of colistin-related nephrotoxicity and risk factors in intensive care unit. North Clin Istanb. 2018;5:120–124. doi:10.14744/nci.2017.4224330374477
   PubMed Web of Science ®Google Scholar